Key facts
- It has raised $140K; the latest was Seed Round ($140K) in Dec 2025.
- Notable investors include Hunan Lushan Technology Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Qiyuyuan Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Qiyuyuan Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qiyuyuan Biotechnology
Manufacturer of bioengineered collagen materials designed to replicate human extracellular matrix for medical and aesthetic applications. The company offers physically induced human collagen fiber networks with stem cell-derived structures and high biocompatibility, enabling medical aesthetics providers, healthcare institutions, and research organizations to achieve effective tissue repair and regenerative outcomes.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Qiyuyuan Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qiyuyuan Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qiyuyuan Biotechnology in its N-PORT filings yet. We sweep new filings monthly.